Author:
Kosakowska-Cholody Teresa,Cholody Wieslaw M.,Hariprakasha Humcha K.,Monks Anne,Kar Siddhartha,Wang Meifang,Michejda Christopher J.,Carr Brian I.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Hariprakasha HK, Kosakowska-Cholody T, Meyer C et al (2007) Optimization of naphthylimido-imidazoacridone with potent anti-tumor activity leading to clinical candidate HKH40A (RTA 502). J Med Chem 50:5557–5560
2. Cholody WM, Kosakowska-Cholody T, Hollingshead MG, Hariprakasha HK, Michejda CJ (2005) A new synthetic agent with potent but selective growth-inhibitory activity against cancer. J Med Chem 48:4474–4481
3. Treason SG, Casas-Finet JR, Cholody WM, Kosakowska-Cholody T, Gryczynski ZK, Michejda CJ (2003) Bisimidazoacridones: 2. Steady-state and time-resolved fluorescence studies of their diverse interactions with DNA. Photochem Photobiol 78:313–322
4. Kosakowska-Cholody T, Cholody WM, Hariprakasha HK et al (2003) WMC79 and HKH40A—potent agent against gastrointestinal cancers: molecular targets and mechanism of action. In: Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, November 17–21, Boston, MA. p 58. (abstract A36)
5. Kosakowska-Cholody T, Cholody WM, Monks A, Woynarowska BA, Michejda CJ (2005) WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway. Mol Cancer Ther 4:1617–1627
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献